Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device

Blood Pressure Clinical Trial

Official title: Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device

Status Completed

Clinical Trial Summary

During the last couple of years, a growing number of wearable devices evolved to provide accurate, cheap and non-invasive monitoring of vitals parameters.This connected care technology could be helpful for treatment and care during a pandemic such as COVID-19. The use of these non-invasive remote monitoring devices can help health care providers to assess patient's vital signs and symptom progression, reducing reducing patient and healthcare provider contact and exposure to COVID-19 during this pandemic.

Clinical Trial Description

Several cuff-less blood pressure monitoring devices have emerged in patient care using photoplethysmography. PPG utilizes an infrared or visible light to measure peripheral volumetric variations of blood circulation and its waveform has been proven to have a good correlation with BP waveform.Nonetheless, the accuracy of these instruments is of fundamental importance.

Several validation procedures for assessing the precision of BP monitoring devices have been developed, including protocols by the Association for the Advancement of Medical Instrumentation, International Organization for Standardization and European Society of Hypertension. Adherence to these guidelines are essential to ensure the effectiveness of BP measurement of the wearable devices.

Therefore, the investigators propose to test wearable low-noise, low-power SENBIOSYS photoplethysmography signals for estimation of BP. ;

Related Conditions & MeSH terms

• Blood Pressure

• NCT number: NCT04379986
• Study type: Interventional
• Source: University of Freiburg
• Status: Completed
• Phase: N/A
• Start date: May 1, 2020
• Completion date: May 31, 2020